Perioperative Critical Care Cardiology - part 1 ppsx

[...]... Circulation 91: 1996–20 01 Uretsky BF, Thygesen K, Armstrong PW et al (2000) Acute coronary findings at 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Sudden Death in Heart Failure: Risk Stratification and Treatment Strategies 15 autopsy in heart failure patients with sudden death Results from the assessment of treatment with lisinopril and survival (ATLAS) study Circulation 10 2: 611 – 616 21 Roberts WC,... ATLEE, 61, 14 5, 17 5 J.O.C AULER JR., 10 9 B BIAGIOLI, 243 A DI LENARDA, 267 P FOËX, 21, 41 F.R.B.G GALAS, G GEMES, 15 9 P GIOMARELLI, 243 H GOMBOTZ, 225 A GULLO, 19 5 L A HAJJAR, 10 9 A HOFER, 225 R HOLSTEN, 13 5 G HOWARD-ALPE, 21, 41 H METZLER, 15 9 W MOOSBAUER, 225 M MORETTI, 267 A PERKAN, 77 A RAPOTEC, 211 G RISTAGNO, 19 5 S ROMAGNOLI, 89 S.M ROMANO, 89 A ROSSI, 89 S SCOLLETTA, 243 G SINAGRA, 1, 77, 267... Cardiol 41: 1707 17 12 Brembilla-Perrot B, Donetti J, Terrier de la Chaise A et al (20 01) Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy Am Heart J 12 1 :11 24 11 31 Fauchier L, Babuty D, Cosnay P et al (2000) Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy Am J Cardiol 85: 618 –623... inducibility of sustained monomorphic venticular tachycardia Am J 16 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 M Zecchin, G Vitrella, G Sinagra Cardiol 71: 113 1 11 41 Moss AJ (2000) Implantable cardioverter defibrillator therapy The sickest patients benefit the most Circulation 10 1 :16 38 16 40 Connolly SJ, Hallstrom AP, Cappato R et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary... origin of syncope J Am Coll Cardiol 21: 110 11 6 28a Gregoratos G, Abrams J, Epstein AE et al (2002) American College of Cardiology, American Heart Association Task Force on Practice Guidelines, North American Society for Pacing and Electrophysiology Committee to Update the 19 98 Pacemaker Guidelines Circulation 10 6 (16 ) 214 5-2 16 1 29 Knight BP, Goyal R, Pelosi F et al (19 99) Outcome of patients with nonischemic... Coll Cardiol 42: 81 87 Marchiali R, Barzi F, Bomba E et al on behalf of the GISSI-Prevenzione Investigators (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction Circulation 10 5 :18 97 19 03 Albert CM, Campos H, Stampefer MJ et al (2002) Blood levels of long chain n-3 fatty acids and the risk of sudden death N Engl J Med 346 :11 13 11 18 Xiao YF, Wright... SORBARA, 89 W TANG, 19 5 W G TOLLER, 15 9 J .- L VINCENT, 13 5, 211 G VITRELLA, 1 M H WEIL, 19 5 M ZECCHIN, 1 1 Sudden Death in Heart Failure: Risk Stratification and Treatment Strategies M ZECCHIN, G VITRELLA AND G SINAGRA Definitions and Epidemiology Attempting a careful evaluation of the incidence of sudden death (SD) in congestive heart failure is inevitably a complex and imprecise task In particular, this... Med 345 :16 67 16 75 Cooper HA, Dries DL, Davis CE et al (19 99) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 10 0 :13 11 13 15 Pitt B, Zannad F, Remme WJ et al for the Randomized Aldosterone Evauation Study Investigators (19 99) The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 3 41: 709– 717 Pitt B, Remme... causes, from 20% (19 86 19 88) to 8% (19 91 19 93) Although a reduction in global mortality has been observed in patients with dilated cardiomyopathy, a reduction in SD remains to be established [9], even though it was found to be lower than expected in more recent trials In the CAT [10 ] trial, expected mortality in the control group according to the literature [11 ] was 12 % However, none of 10 9 study patients... ACE-I, digitalis, and diuretic treatment A 65% reduction in total mortality in the carvedilol group was observed compared to the placebo group The incidence of SD at 10 -month follow-up was 1. 7% in the carvedilol group, and 3.8% in the placebo group The MERIT-HF [15 ] study randomized 39 91 patients with heart failure and LVEF below 40% to metoprolol or placebo (in addition to digitalis and ACE-I) A 41% . Control Number: 2006937626 ISBN -1 0 8 8-4 7 0-0 55 7-4 Springer Milan Berlin Heidelberg New York ISBN -1 3 97 8-8 8-4 7 0-0 55 7-0 Springer Milan Berlin Heidelberg New York Springer is a part of Springer Science+Business.